Lab21 appoints Susan Lowther as Chief Financial Officer
Lab21 Limited announced the appointment of Susan Lowther as Chief Financial Officer.
Susan brings a wealth of experience, gained over 20 years in the pharmaceutical, biotech and healthcare industries. She has extensive financial management expertise, gained from working with start up companies to global PLCs, covering both public and private financing, including venture capital financing and IPOs. Susan also has extensive experience of M&A activity, including acquisition and divestment.
Susan has held senior management positions at BioWisdom, RiboTargets, Lonza Biologics, Celltech and Monsanto.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.